Digital Treatment for Osteoarthritis Superior to Traditional Routine Care

Joint AcademyFirst-line treatment of knee osteoarthritis is effectively delivered digitally without a need for traditional face-to-face physiotherapy visits, a new study finds. The research, independently undertaken by the University of Nottingham, led by Prof Ana Valdes from the Nottingham NIHR Biomedical Research Centre using Joint Academy's clinical and evidence-based digital treatment for chronic joint pain, addresses a rapidly growing health concern as hospital waiting lists are mounting while the NHS is expected to spend £118.6 billion on treating arthritis between 2017 and 2027 alone. The study, published today, shows that UK patients receiving digital treatment reduced their pain by 41 per cent, while the same number for patients receiving usual care landed at merely 6 per cent.

"We already knew that digital first-line treatment substantially improves symptoms of osteoarthritis at a significantly reduced cost compared to face-to-face care. This study is the first randomised controlled trial that demonstrates clinically important improvements of digital treatment compared to the traditional one and firmly establishes how effective digital treatment actually is in relation to traditional self-management care," says Leif Dahlberg, Chief Medical Officer at Joint Academy and Senior Professor in Orthopedics.

A total of 105 people, who were 45 years or older with a diagnosis of knee osteoarthritis, participated in the study. They were allocated at random to two groups where one was treated digitally and the other group self-managed their symptoms according to NICE guidelines. Patients in the digital treatment were connected with licensed physiotherapists via a smartphone application where they received education and daily exercises. Patients in the other group continued their traditional self-management programme according to guidelines and visited their general practitioner when needed. In addition to experiencing substantially less pain than the control group, the patients receiving digital treatment also reported that their physical function increased by 48 per cent - a stark improvement to traditional treatment where physical function increased by only 13 per cent.

"The results of the study really show how much can be gained by treating chronic knee pain digitally, and this will reduce the burden on the NHS, especially when we are going through the COVID-19 pandemic where services are already stretched. We hope this study allows health policy-makers to consider the potential in digital alternatives when it comes to treating knee arthritis," says Sameer Akram Gohir, physiotherapist and researcher at the University of Nottingham.

Osteoarthritis is one of the world’s fastest-growing and most costly chronic diseases. Figures from the NHS show that nearly 9 million people are impacted in the UK alone and Arthritis Research UK estimates that roughly 20 per cent of the English population aged 45 and over suffer from osteoarthritis of the knee, but the recommended first-line treatment, consisting of information, exercise and weight control when needed, is underutilised.

"The study shows the positive impact digital treatment has on the osteoarthritis burden for both patients and healthcare systems. Besides the beneficial outcomes in pain and physical function, the advantages of digital treatment are also lower costs and more easily accessible care for those living in remote areas far from the nearest physiotherapist," Dahlberg concludes.

Joint Academy connects patients with licensed physiotherapists to deliver its evidence-based osteoarthritis treatment through telehealth, making it a safe treatment option during the COVID-19 pandemic. Already one of the main providers of chronic joint pain treatment in Sweden, Joint Academy is planning to expand across the UK throughout 2021.

About the study

The study was conducted by an independent group of five researchers at the University of Nottingham in the UK during a period of six weeks. 105 people aged 45 and over and diagnosed with knee osteoarthritis participated in the study. All participants had a face-to-face meeting during enrolment. The treatment was then delivered digitally to the intervention group using Joint Academy’s clinical and evidence-based digital treatment for osteoarthritis, whereas the patients in the control group continued a traditional self-management programme according to general guidelines and visited a general practitioner when needed. The study is named "Randomised controlled trial of Digitally delivered first-line knee osteoarthritis treatment: the Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA) study" and was published in JAMA Network Open on February 23, 2021. The study can be found in full here.

About Joint Academy

Joint Academy is a treatment program based on clinical evidence and connects patients with licensed physiotherapists for a chronic joint pain treatment online. Through the program, patients receive important information and support to do necessary lifestyle changes that are sustainable, as well as individualized exercises to strengthen the affected joints and increase their function. The patients have a personal physiotherapist that guides them through the entire treatment.

Most Popular Now

Senior Nurse adds to Clinical Expertise …

A senior nurse with more than 20 years' experience in the NHS has joined smart health tech provider Alcidion in a core role as a clinical consultant primarily working with...

Artificial Intelligence in the Real Worl…

Royal Bolton NHS Foundation Trust has been much praised for its deployment of AI in the fight against Covid-19. Rizwan Malik, divisional medical director of the trust and managing director...

Philips Introduces ClarifEye Augmented R…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced ClarifEye Augmented Reality Surgical Navigation, an industry-first solution to advance minimally-invasive spine procedures in the Hybrid...

Wearable Devices can Detect COVID-19 Sym…

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first...

Philips completes the acquisition of Bio…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote...

Siemens Healthineers and Kantonsspital B…

Siemens Healthineers and the Kantonsspital Baden (KSB) in Switzerland, a networked, regional center of competence, have formed a long-term, strategic and technological partnership for the next eight years. This "Value...

A Machine-Learning Approach to Finding T…

When the COVID-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare. "Making new drugs takes forever," says Caroline Uhler...

Computational Medicine - Moving from Unc…

Individual choices in medicine carry a certain amount of uncertainty. An innovative partnership at The University of Texas at Austin takes aim at medicine down to the individual level by applying...

Bury, Oldham, Rochdale and Trafford Go L…

Nearly half a million children's health records across Bury, Oldham, Rochdale and Trafford have been successfully integrated onto a new child health information system to support services in each area. The...

Medway Picks Allscripts Sunrise EPR to M…

Medway NHS Foundation Trust is looking to make rapid improvements in its digital maturity with the Allscripts Sunrise electronic patient record. The Kent trust signed a contract with Allscripts in December...

Cybersecurity in Healthcare: HubIT Final…

17 February 2021, Online. The online international workshop "Cybersecurity within Healthcare Systems" takes place on the 17 of February 2021 from 10-13 am CET. The aim of this workshop is to...